ATE125269T1 - Radiomarkierte peptide mit antikoagulanswirkung. - Google Patents

Radiomarkierte peptide mit antikoagulanswirkung.

Info

Publication number
ATE125269T1
ATE125269T1 AT90118902T AT90118902T ATE125269T1 AT E125269 T1 ATE125269 T1 AT E125269T1 AT 90118902 T AT90118902 T AT 90118902T AT 90118902 T AT90118902 T AT 90118902T AT E125269 T1 ATE125269 T1 AT E125269T1
Authority
AT
Austria
Prior art keywords
radiom
anticoagulate
effect
labeled peptides
peptides
Prior art date
Application number
AT90118902T
Other languages
English (en)
Inventor
John L Krstenansky
Simon J T Mao
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE125269T1 publication Critical patent/ATE125269T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/815—Protease inhibitors from leeches, e.g. hirudin, eglin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT90118902T 1989-10-03 1990-10-03 Radiomarkierte peptide mit antikoagulanswirkung. ATE125269T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41633589A 1989-10-03 1989-10-03

Publications (1)

Publication Number Publication Date
ATE125269T1 true ATE125269T1 (de) 1995-08-15

Family

ID=23649537

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90118902T ATE125269T1 (de) 1989-10-03 1990-10-03 Radiomarkierte peptide mit antikoagulanswirkung.

Country Status (18)

Country Link
US (1) US5279812A (de)
EP (1) EP0421366B1 (de)
JP (1) JP2899390B2 (de)
KR (1) KR0168644B1 (de)
CN (1) CN1050721A (de)
AT (1) ATE125269T1 (de)
AU (1) AU631681B2 (de)
CA (1) CA2026377A1 (de)
DE (1) DE69021000T2 (de)
ES (1) ES2076999T3 (de)
FI (1) FI904851A7 (de)
HU (1) HU207525B (de)
IE (1) IE903531A1 (de)
IL (1) IL95864A0 (de)
NO (1) NO904291L (de)
NZ (1) NZ235499A (de)
PT (1) PT95485A (de)
ZA (1) ZA907743B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395609A (en) * 1989-06-19 1995-03-07 Antisoma Limited Synthetic peptides for use in tumor detection
GB8914020D0 (en) * 1989-06-19 1989-08-09 Antisoma Ltd Synthetic peptides for use in thrombus detection
US5574012A (en) * 1990-07-24 1996-11-12 Merrell Pharmaceuticals Inc. Analogs of hirudin having anti-platelet activity
AU640502B2 (en) * 1990-07-24 1993-08-26 Merrell Dow Pharmaceuticals Inc. Analogs of hirudin having antiplatelet activity
DK0540574T3 (da) * 1990-07-24 1996-09-30 Merrell Pharma Inc Antikoagulationspeptider
WO1993004082A1 (en) * 1991-08-20 1993-03-04 Baxter International Inc. Analogs of hirudin
JPH08504166A (ja) * 1992-02-05 1996-05-07 マリンクロッド・メディカル・インコーポレイテッド 放射標識ペプチド化合物
US5371184A (en) * 1992-02-05 1994-12-06 Mallinckrodt Medical, Inc. Radiolabelled peptide compounds
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
US5750088A (en) 1993-03-30 1998-05-12 The Dupont Merck Pharmaceutical Company Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals
NZ268159A (en) * 1993-06-11 1997-03-24 Merrell Pharma Inc Anticoagulant and antiplatelet peptides and their use
US5457177A (en) * 1993-06-16 1995-10-10 Merck & Co., Inc. Thrombin receptor radioligands
WO1995032173A1 (en) * 1994-05-24 1995-11-30 Eisai Co., Ltd. Compound bearing two 2,6-diiodophenol-4-yl groups and diagnostic drug for iodine allergy
US5808146A (en) * 1995-11-09 1998-09-15 Emory University Amino acid analogs for tumor imaging
US6808698B1 (en) 1999-03-26 2004-10-26 Bristol-Myers Squibb Pharma Company Method for localization of blood clots
US6254852B1 (en) 1999-07-16 2001-07-03 Dupont Pharmaceuticals Company Porous inorganic targeted ultrasound contrast agents
US6685914B1 (en) * 1999-09-13 2004-02-03 Bristol-Myers Squibb Pharma Company Macrocyclic chelants for metallopharmaceuticals
WO2003093412A2 (en) * 2002-04-30 2003-11-13 Emory University Tumor imaging compounds
US7319149B2 (en) * 2003-06-13 2008-01-15 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
US7317104B2 (en) 2003-06-13 2008-01-08 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
CN100402092C (zh) * 2005-06-07 2008-07-16 西安交通大学 血栓诊断和/或治疗用含气干粉活性剂及其制备工艺
AU2006262425C1 (en) * 2005-06-23 2012-06-21 Emory University Stereoselective synthesis of amino acid analogs for tumor imaging
JP2009505947A (ja) * 2005-06-23 2009-02-12 エモリー・ユニバーシティ 画像化剤
US8246752B2 (en) 2008-01-25 2012-08-21 Clear Catheter Systems, Inc. Methods and devices to clear obstructions from medical tubes
CN110437307B (zh) * 2019-07-26 2020-11-13 暨南大学 一类具抗血栓和脑神经细胞保护作用的水蛭多肽及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5850213B2 (ja) * 1977-06-20 1983-11-09 株式会社第一ラジオアイソト−プ研究所 カルチトニンの定量法
DE3040824A1 (de) * 1980-10-30 1982-08-19 Dr. Karl Thomae Gmbh, 7950 Biberach Neues dekapeptid, verfahren zu seiner herstellung und verwendung
US4455290A (en) * 1981-04-02 1984-06-19 Research Corporation Inhibition of fibrin polymerization by a peptide isolated from fibrin Fragment D1
US4585740A (en) * 1983-05-03 1986-04-29 The Whittier Institute For Diabetes And Endocrinology Prolactin immunoassay using synthetic peptide
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
EP0209061B1 (de) * 1985-07-17 1994-01-12 Hoechst Aktiengesellschaft Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel
CA1341032C (en) * 1987-01-23 2000-06-20 John L. Krstenansky Anticoagulant peptides
CA1340646C (en) * 1987-05-21 1999-07-13 John L. Krstenansky Cyclic anticoagulant peptides
ZA883444B (de) * 1987-05-21 1988-11-16
AU3098289A (en) * 1988-03-04 1989-09-07 Biogen, Inc. Hirudin peptides
DE58907266T2 (de) * 1988-06-11 1994-09-29 Ciba Geigy Ag Polypeptide mit einer die Koagulierung hemmenden Wirkung.
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides

Also Published As

Publication number Publication date
ES2076999T3 (es) 1995-11-16
HUT55801A (en) 1991-06-28
CA2026377A1 (en) 1991-04-04
PT95485A (pt) 1991-06-25
IL95864A0 (en) 1991-07-18
NO904291L (no) 1991-04-04
EP0421366A1 (de) 1991-04-10
KR0168644B1 (ko) 1999-01-15
ZA907743B (en) 1991-07-31
JPH03120296A (ja) 1991-05-22
CN1050721A (zh) 1991-04-17
NO904291D0 (no) 1990-10-02
EP0421366B1 (de) 1995-07-19
DE69021000T2 (de) 1996-04-04
AU631681B2 (en) 1992-12-03
HU207525B (en) 1993-04-28
DE69021000D1 (de) 1995-08-24
HU906271D0 (en) 1991-03-28
JP2899390B2 (ja) 1999-06-02
IE903531A1 (en) 1991-04-10
AU6368990A (en) 1991-04-11
KR910007959A (ko) 1991-05-30
NZ235499A (en) 1993-04-28
FI904851A0 (fi) 1990-10-02
FI904851A7 (fi) 1991-04-04
US5279812A (en) 1994-01-18

Similar Documents

Publication Publication Date Title
DE69021000D1 (de) Radiomarkierte Peptide mit Antikoagulanswirkung.
ATE193839T1 (de) Reinigung von proteinen
ES2113865T3 (es) Gen pnc humano y proteina precursora.
DE3851238D1 (de) Antikoagulierende Peptide.
DE69032258D1 (de) Antikoagulierende Peptide
DK226889A (da) Alkoholpeptidderivat samt anvendelse deraf til mindskning af blodkoagulation
DE68928942D1 (de) Antikoagulierende Peptide
ATE139121T1 (de) Hirudin-analoge mit antiblutplättchen-aktivität
DK0540574T3 (da) Antikoagulationspeptider
DK369888A (da) Peptidforbindelser

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee